Agenda

Clinical Implications of Neuropsychiatry

(Agenda subject to change. Please check back for updates)

Friday, June 15, 2018

6:45 AM

Breakfast / Exhibits

7:15 AM - 8:00 AM

Breakfast Symposium (non-CME)
Breakthrough for Addressing the Multiple Root Causes of Alzheimer’s Disease:
Combined Ingredients Provide a Synergistic Integrative Approach
Faculty: James M. Greenblatt, MD
Sponsored by: Jaymac Pharmaceuticals

8:00 AM - 8:15 AM

Welcome
Henry A. Nasrallah, MD

8:15 AM - 9:00 AM

Ketamine Reversal of Treatment-Resistant Depression and Suicidality: a Major Paradigm Shift 
Charles Raison, MD

9:00 AM - 9:05 AM

Q & A

9:05 AM - 9:50 AM

The Evolving Neuropsychiatry of Depression
Charles Raison, MD 

9:50 AM - 10:00 AM

Q & A

10:00 AM - 10:30 AM

Break/Exhibits

10:30 AM - 11:15 AM

The Evaluation and Differential Diagnosis of Dementia: A Model for the Neuropsychiatric Assessment
Part 1: Assessment
Constantine G. Lyketsos, MD, MHS

11:15 AM - 11:20 AM

Q & A

11:20 AM - 12:05 PM

The Evaluation and Differential Diagnosis of Dementia: A Model for the Neuropsychiatric Assessment
Part 2: Differential Diagnosis
Constantine G. Lyketsos, MD, MHS

12:05 PM - 12:15 PM

Q & A 

12:15 PM - 12:30 PM

Lunch

12:30 PM - 1:30 PM

Lunch Symposium (non-CME)
Understanding Business Tools Used to Eliminate Lawsuits and Increase Tax Savings
Speaker: Art McOmber
Sponsored by: Legally Mine

1:30 PM - 2:00 PM

Dessert Break/Exhibits

2:00 PM - 2:45 PM

Schizophrenia: Clinical Manifestations and Management of its Neurodevelopmental and Neurodegenerative Stages
Henry A. Nasrallah, MD

2:45 PM - 3:30 PM

Psychiatric Aspects of Parkinson’s Disease: Evaluation and Management
Laura Marsh, MD

3:30 PM - 3:45 PM

Q & A Panel Discussion

3:45 PM - 4:30 PM

Bipolar Disorder: The Neurological and Clinical Malignancy of Recurrent Episodes
Henry A. Nasrallah, MD

4:30 PM - 5:15 PM

Psychiatric Disturbances in Epilepsy: Evaluation and Management
Laura Marsh, MD

5:15 PM - 6:00 PM

The Neuropsychiatry and Management of ADHD
Part 1: Diagnostic Assessment and Treatment
Jeffrey R. Strawn, MD, FAACAP

6:00 PM - 6:15 PM

Q & A Panel Discussion

6:15 PM

Evening Adjournment

Saturday, June 16, 2018

7:00 AM

Breakfast / Exhibits

8:00 AM - 8:45 AM

The Neuropsychiatry and Management of ADHD
Part 2: Neurobiology of Treatment
Jeffrey R. Strawn, MD, FAACAP

8:45 AM - 8:50 AM

Q & A

8:50 AM - 9:35 AM

Management of Aggression and Impulsivity
Eric Hollander, MD

9:35 AM - 9:45 AM

Q & A

9:45 AM - 10:15 AM

Break/Exhibits

10:15 AM - 11:00 AM

Traumatic Brain Injury
Thomas W. McAllister, MD

11:00 AM - 11:45 AM

Autism
Eric Hollander, MD

11:45 AM - 12:00 PM

Q & A Panel Discussion

12:00 PM - 12:15 PM

Lunch

12:15 PM - 1:15 PM

Lunch Symposium (non-CME)
A Long-acting Injectable (LAI) Treatment for Schizophrenia Including a 2-Month (1064 mg) Dosing Interval Option
Faculty: Kent McDaniel, MD, PhD, ABPN
Sponsored by: Alkermes

1:15 PM - 1:30 PM

Dessert Break/Exhibits

1:30 PM - 2:15 PM

Sports Concussions: What We Know and What We Need to Know
Thomas W. McAllister, MD

2:15 PM - 3:00 PM

Psychopharmacology in Neuropsychiatry: The Five Steps to Success in Managing Tardive Dyskinesia
Leslie Citrome, MD, MPH

3:00 PM - 3:05 PM

Q & A Panel Discussion

3:05 PM - 3:50 PM

Psychopharmacology in Neuropsychiatry: What Works for Parkinson's Disease Psychosis?
Leslie Citrome, MD, MPH

3:50 PM - 4:00 PM

Q & A Panel Discussion

4:15 PM

Conference Adjournment

As a result of participating in this activity, participants should be able to:

• Review the neuropsychiatric manifestations of epilepsy and strategies for their management.
• Review the neuropsychiatric manifestations of Parkinson's Disease and the latest strategies for their management.
• Describe the structural brain abnormalities in bipolar disorder and the effects of relapses and pharmacotherapy.
• Explain the abnormalities in brain circuits and the symptom domains of schizophrenia and the emerging new therapies for schizophrenia.
• Implement appropriate strategies to perform a Neuropsychiatric Mental Status Exam beyond the standard mental status assessment.
• Describe the association between participation in collision sports and long term neuropsychiatric problems.
• Identify the varieties of traumatic brain injury, their neuropsychiatric impact and their treatments.
• Recognize the neurological roots of ADHD and their relationship to symptoms and treatments.
• Recognize and assess current and emerging neuropsychiatric findings and therapeutic options for patients with autism and its neurobehavioral manifestations.
• Explain the neurobiological effects of ketamine and how they translate into improvement in treatment-refractory depression.